Thonzylamine
Thonzylamine (or neohetramine)[1] is an antihistamine and anticholinergic used as an antipruritic.
 | |
| Clinical data | |
|---|---|
| Other names | Neohetramine |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.001.913  |
| Chemical and physical data | |
| Formula | C16H22N4O |
| Molar mass | 286.379 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
  | |
Synthesis
Thonzylamine synthesis: H. L. Friedman and A, V. Tolstouhov, U.S. Patent 2,465,865 (1949).
See also
- Zolamine
References
- Arminio JJ, Sweet CC (December 1949). "The prophylaxis and treatment of the common cold with neohetramine (thonzylamine hydrochloride)". Industrial Medicine & Surgery. 18 (12): 509–11. PMID 15393969.
Antipruritics (D04) | |
|---|---|
| Antihistamines for topical use |
|
| Anesthetics for topical use |
|
| Others | |
Decongestants and other nasal preparations (R01) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical |
| ||||||||||
| Systemic use: Sympathomimetics |
| ||||||||||
| |||||||||||
Antihistamines (R06) | |
|---|---|
| Benzimidazoles (*) |
|
| Diarylmethanes |
|
| Ethylenediamines |
|
| Tricyclics |
|
| Others |
|
| For topical use |
|
Acetylcholine receptor modulators | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||
Histamine receptor modulators | |
|---|---|
| H1 |
|
| H2 |
|
| H3 |
|
| H4 | |
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.